According to a newly published market research report by 24LifeSciences, global postmenopausal osteoporosis therapeutics market was valued at USD 11.2 billion in 2023 and is projected to reach USD 17.4 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.7% during the forecast period 20242031. Postmenopausal osteoporosis therapeutics comprise pharmaceutical treatments designed...